Hold LIN as seven-decision history mandates; maintain current weight with predefined re-entry triggers at $478.20 and invalidation at $385
Hold existing LIN exposure without trimming or adding. The franchise floor (80% contracted revenue, A-rated credit, 31-year dividend growth, $4.16B FCF) caps downside justifying Hold over Underweight. The regime gate disqualifies starters (structural deterioration documented alongside technical setup) justifying Hold over Buy. Both Research Manager and Trader converge on Hold, mandated by seven-decision lesson history showing zero cumulative alpha across prior six LIN decisions. Reassess at Q3 2026 earnings as next binary fundamental catalyst.
A 16% pullback in a best-in-class compounder with 18% ROE, expanding 28% operating margins, and double-digit EPS growth, combined with high-signal institutional accumulation and a self-supporting capital return floor, makes the current technical weakness an asymmetric buying opportunity.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 33.04 | bearish |
| MACD Line | -7.46 | bearish |
| MACD Signal | -6.07 | bearish |
| MACD Histogram | -1.38 | bearish |
| 10 EMA | 470.31 | bearish |
| 20 SMA (BB Middle) | 478.29 | bearish |
| 50 SMA | 492.54 | bearish |
| 200 SMA | 479.08 | bearish |
| ATR (14) | 7.85 | neutral |
| Bollinger Upper Band | 497.48 | neutral |
| Bollinger Lower Band |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
EV: +5.7% · concedes: The chart is technically ugly with no bullish RSI divergence yet; The 50 SMA still needs to catch down toward price; The macro backdrop is genuinely messy (10Y at 5%, recession odds at 16%); Sundheim position was initiated in Q2 and market may have moved since
Linde is a great company but not a great buy at $462 — the chart is broken, the macro is hostile (5% 10Y, Fed priced to hike, oil shock hitting costs), and the bull case requires multiple favorable scenarios to align simultaneously while the bear case only requires the downtrend to continue.
· concedes: Linde is a great company with real fundamentals; Q2'26 EPS did grow +11.3% YoY to $4.15; The fundamentals section is well-organized; Beta 0.73 means Linde has held up better than Nasdaq
→ vs neutral: HOLD verdict is correct in direction but too timid in execution; waiting for macro to clear or chart confirmation means missing the move as quality compounders rip when least expected and the marginal buyer is forced to chase
→ vs conservative: Macro caution is the biggest mistake; 10-year at 5%, recession odds at 16% (up 9 points), and $110 oil actually favor LIN as a defensive compounder with beta of 0.73 and positive merchant gas volume tailwinds
→ vs aggressive: Technical analyst's SELL is inexplicable given their own admission of a tactical bounce to 470-478 and that 478 is the structural reclaim level that invalidates the bear case; if path of least resistance is a bounce, why recommend selling into it
| 459.09 |
| neutral |
| Price vs 200 SMA | Below (~3.4%) | bearish |
| Price vs 50 SMA | Below (~6%) | bearish |
Support: 459.09 · 440 · 395 · 400 · 385.58 | Resistance: 470.31 · 478.29 · 492.54 · 497.48
Linde plc exhibits a stacked bearish configuration with price (462.96) below all three moving averages and the 200-day SMA (479.08) recently breached to the downside. RSI at 33.04 sits near oversold without bullish divergence, indicating bearish persistence rather than exhaustion. MACD is deeply negative at -7.46 with a worsening histogram of -1.38, while price has tagged the lower Bollinger Band at 459.09—an extreme condition occurring less than 5% of the time. ATR has compressed to 7.85 from ~10.2 in mid-August, forming a volatility squeeze that typically precedes directional expansion. The report recommends SELL/defensive posture, waiting for stabilization signals such as price reclaiming the 10 EMA (470.31) on a closing basis and RSI sustained above 50 before considering fresh longs.
Market Cap
$213.4B
P/E (TTM)
29.85x
Forward P/E
23.67x
PEG Ratio
1.81
P/B
5.46x
Dividend Yield
1.38%
Beta
0.73
52-Week High
$548.20
52-Week Low
$387.78
50-Day MA
$495.46
200-Day MA
$481.83
Revenue (TTM)
$35.45B
Gross Profit (TTM)
$17.14B
EBITDA (TTM)
$13.82B
Net Income (TTM)
$7.24B
Operating Margin
28.1%
Net Profit Margin
20.4%
ROE
18.4%
ROA
7.2%
Q2'26 Revenue YoY Growth
+9.3%
Q2'26 EPS YoY Growth
+11.3%
Q2'26 Operating Income YoY Growth
+8.5%
Total Assets (Q2'26)
$88.35B
Total Debt (Q2'26)
$28.01B
Net Debt (Q2'26)
$23.12B
Stockholders' Equity (Q2'26)
$39.08B
Net Debt / EBITDA
~1.7x
Current Ratio (Q2'26)
0.88
Free Cash Flow (TTM)
$4.16B
Capex (TTM est.)
~$5.5B
Dividends Paid (TTM est.)
~$2.84B
Buybacks (TTM est.)
~$5.16B
EPS (TTM)
$15.51
Forward EPS
$19.56
Book Value Per Share
$84.78
Diluted Share Count YoY Change
-1.9%
Strengths
Concerns
Linde plc is the world's largest industrial gases and engineering company with a market cap of $213.4B, delivering Q2'26 revenue of $9.29B (up 9.3% YoY) and EPS of $4.15 (up 11.3% YoY), supported by best-in-class profitability metrics including 28.1% operating margin and 18.4% ROE. The company generates approximately $4.16B in annual free cash flow and returns roughly 65% to shareholders through dividends (1.38% yield) and ~$5.16B in annual buybacks, while maintaining a conservative leverage ratio of 1.7x net debt to EBITDA despite the heavy share repurchase program.
Macro: The broader macro regime is hawkish, inflation-sticky, and oil-heavy: U.S. 10Y briefly topped 5.0% (first time since 2023 / 19-year high); Fed rate-cut odds by Sept 2026 are 0%, by Oct 2026 are 3%, and by Dec 2026 are 4% (Polymarket); U.S. recession odds by end-2026 stand at 16% (+9.0pp week-over-week); WTI crude $110 in September implied at 55% (+42.5pp week-over-week). This backdrop is modestly negative for LIN via multiple compression (higher discount rates) and cyclical risk, but provides mild positive offsets via oil-field-services and petrochem volume demand.